Jeff Hosry MD

Articles by Jeff Hosry MD

The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study

ByKira MacDougall, MD,Muhammad Rafay Khan Niazi, MD,Jeff Hosry MD,Sylvester Homsy, MD,Alexander Bershadskiy, MD

March 16th 2022

Kira MacDougall, MD, and co-investigators, research the importance of peripheral biomarkers in patients with advanced non–small cell lung cancer who are treated with pembrolizumab.

Latest Updated Articles

The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study
March 16th 2022

Jeff Hosry MD

Articles by Jeff Hosry MD

The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study

Latest Updated Articles

Trending on CancerNetwork

177Lu-Edoterotide Handed CRL by FDA For GEP-NETs Treatment

DESTINY Trials May Reshape HER2-Positive Breast Cancer Care With T-DXd

BI-1808 Earns FDA Fast Track Status for Advanced Ovarian Cancer

Divesiran Shows Clinical Responses in Phase 2 Polycythemia Vera Trial

How Is City of Hope Widening National Clinical Trial Access for Oncology?